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Abstract
In this work, deoxyribose-5-phosphate aldolase (Ec DERA, EC 4.1.2.4) from Escherichia coli was chosen as the protein
engineering target for improving the substrate preference towards smaller, non-phosphorylated aldehyde donor substrates, in
particular towards acetaldehyde. The initial broad set of mutations was directed to 24 amino acid positions in the active site or in
the close vicinity, based on the 3D complex structure of the E. coliDERA wild-type aldolase. The specific activity of the DERA
variants containing one to three amino acid mutations was characterised using three different substrates. A novel machine
learning (ML) model utilising Gaussian processes and feature learning was applied for the 3rd mutagenesis round to predict
new beneficial mutant combinations. This led to the most clear-cut (two- to threefold) improvement in acetaldehyde (C2) addition
capability with the concomitant abolishment of the activity towards the natural donor molecule glyceraldehyde-3-phosphate
(C3P) as well as the non-phosphorylated equivalent (C3). The Ec DERA variants were also tested on aldol reaction utilising
formaldehyde (C1) as the donor. Ec DERA wild-type was shown to be able to carry out this reaction, and furthermore, some of
the improved variants on acetaldehyde addition reaction turned out to have also improved activity on formaldehyde.
Key points
• DERA aldolases are promiscuous enzymes.
• Synthetic utility of DERA aldolase was improved by protein engineering approaches.
• Machine learning methods aid the protein engineering of DERA.
Keywords DERA . Aldolase . Protein engineering . Machine learning . Crystal structure determination . C–C bond formation .
Biocatalysis
Introduction
Aldolases are enablers of industrial biocatalysis as they can
promote carbon-carbon (C–C) bond formation, which is one
of the essential reactions in synthetic chemistry. Aldol reac-
tion can be catalysed by the lyase (EC4) or transferase class
(EC2) of enzymes, found in the metabolic pathways in all
three domains of life (archaea, bacteria, eukarya). Aldolases
catalyse the reversible formation of C–C bonds by the aldol
addition of a nucleophilic donor, typically a ketone enolate,
onto an electrophilic aldehyde acceptor (Scheme 1).
Aldolase type of enzymes have been found to be promis-
cuous capable of using a broad range of aldehydes as accep-
tors, whereas the donor compound is often structurally
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invariable. Hence, aldolases can be classified according to
their donor specificity to, e.g. acetaldehyde-dependent aldol-
ases. Another way to classify these enzymes relates to the
different catalytic mechanisms to activate the nucleophilic
component. The class I aldolases do not require any cofactor,
but exhibit a conserved lysine residue in the active site which
forms a Schiff base intermediate with the donor compound to
generate an enamine nucleophile.
Deoxyribose-5-phosphate aldolases (DERA, EC 4.1.2.4)
are a class I aldolase that catalyses in vivo the reversible ad-
dition of the donor molecule, acetaldehyde (C2), to the accep-
tor molecule, glyceraldehyde 3-phosphate (C3P). DERA is
known to be promiscuous in its substrate range as it accepts
a wide variety of different acceptor molecules (Chen et al.
1992; Gijsen and Wong 1994). In addition, at the donor site
o f DERA enzyme ace t one , f l uo roa c e t one and
propionaldehyde (propanal) have been reported to function
(with strongly reduced reaction rates) besides the acetalde-
hyde (Barbas et al. 1990; Chen et al. 1992). An interesting
and unique feature, particularly in terms of synthesis reactions,
is the ability of DERA to catalyse sequential acetaldehyde
addition (Gijsen and Wong 1994). Here, the first aldol addi-
tion reaction creates an aldehyde product, which functions as
an acceptor for the subsequent DERA-catalysed
stereoselective aldol reaction to add another aldehyde donor
substrate. This cascade reaction has been utilised for addition
of two equivalents of acetaldehyde to one equivalent of
chloroacetaldehyde in the preparation of (3R,5S)-6-chloro-
2,4,6-trideoxyhexose, a chiral precursor for the sidechain of
the statin drugs (Oslaj et al. 2013). The capacity of wild-type
DERA to catalyse aldol addition is, however, rather low. To
increase the aff ini ty of the E. col i aldolase for
chloroacetaldehyde acceptor and stability against high acetal-
dehyde concentrations, researchers at DSM applied a directed
evolution approach (Jennewein et al. 2006). By screening for
and combining beneficial mutations, they succeeded in iden-
tifying an improved variant with 10-fold improved productiv-
ity in E. coli under industrially relevant conditions.
Advances in computational chemistry combined with pro-
tein engineering strategies have most recently opened new
possibilities for more efficient design of enzymatic catalysts
for chemical reactions (Linder 2012; Kiss et al. 2013;Mak and
Siegel 2014; Jindal et al. 2019). The aim of this work was to
engineer DERA aldolase to accept smaller non-
phosphorylated acceptor substrates in the aldol addition reac-
tion with acetaldehyde. The work included evaluating first the
most suitable DERA aldolase for the protein engineering
work, by expressing, purifying and characterising a set of
DERA enzymes of different origin. After that, we used differ-
ent types of mutagenesis approaches in combination with a
novel machine learning model to create DERA variants in
three mutagenesis rounds, which were screened using a panel
of different substrates. Crystal structures of some of the most
interesting DERA variants were also solved to provide more
insight.
Materials and methods
Cloning, protein expression and purification of
different DERAs
Seven DERA encoding genes from different organisms (1.
DERA [UniProt P0A6L0]-coding gene [deoC] from E. coli,
2. DERA [NCBI Reference Sequence: WP_047758083.1] -
coding gene fromGeobacillus, 3. DERA [SwissProt Q5SJ28]
-coding gene from Thermus thermophilus, 4. DERA [UniProt
E0CX06] -coding gene from Coccidioides immitis, 5. DERA
[UniProt Q03Q50]-coding gene from Lactobacillus brevis, 6.
DERA [GenBank CRG82919.1]-coding gene from
Talaromyces islandicus and 7. DERA [NCBI Reference
Sequence: XP_003188826.1]-coding gene from Aspergillus
niger) were cloned and expressed in E. coli. All of them were
codon optimised for E. coli and synthesised with an N-
terminal 6x His-tag by Integrated DNA Technologies as so
called G-blocks. Histidine tag was added to the N-terminus as
it has been shown that the C-terminal tail of EcDERA has a
role in the catalytic activity (Schulte et al. 2018). For the
codon-optimised nucleotide sequences, see “GenBank acces-
sion numbers” section. The synthetic DNA blocks were
cloned into the pBAT4 vector (Peränen et al. 1996) linearised
with NcoI and XhoI restriction enzymes. The synthesised in-
sert contained 60 bp overlapping regions in both 5′ and 3′ ends
to the vector to allow cloning with Gibson assembly method
(Gibson et al. 2009) using Gibson assembly® master mix
(New England Biolabs). After assembly, the mixtures were
transformed into chemical competent XL1-blue E. coli cells.
Single point mutations of E. coli DERA (Ec DERA) were
made with Q5®site-directed mutagenesis kit (New England
Biolabs) (list of primers is shown in Table S1) and verified by
sequencing (Source BioScience or Microsynth). Some amino
acid positions were mutated by using degenerated primers to
Scheme 1 Aldolases catalyse the
reversible formation of C–C
bonds by the aldol addition of a




generate a selection of amino acid mutations in one PCR re-
action. For example, position L20 was mutagenised using
forward primer 5 ′-GTTGATGGACSDNACCACTC
TGAACG-3′ to generate mutations L20R, Q, E, H, V, D, G
simultaneously. Nucleotide code S stands for G or C and D
stands for A, G or T.
Double mutants (containing two point mutations/gene) and
some of the triple mutants (containing three point mutations/
gene) of Ec DERA were generated in a similar manner as for
the single mutants by using already existing single mutant in
question as the template in the PCR mutagenesis. The triple
mutant variants suggested by machine learning were ordered
as synthetic DNA blocks from Integrated DNA Technologies,
similarly to the wild-type DERA genes described above.
Saturation mutagenesis was done by PCR using so called
22c-trick (Kille et al. 2013). The method reduces codon re-
dundancy from often-used saturation mutagenesis method
using codon NNK.
DERA variants were expressed in E. coli BL21(DE3)
strain in LB-medium containing 100 μg/ml ampicillin.
DERA wild-type enzymes from different organisms and
E c DERA mu t a n t s N 2 1K a n d t r i p l e m u t a n t
C47V/G204A/S239D, which were crystallised for 3D
structure determination, were cultivated in 50-ml scale
and all other Ec DERA mutants were cultivated in 3-ml
or 10-ml scale. The expression strains were cultivated for
6–8 h in 37 °C after which the expression was induced with
0.5 mM IPTG, and after 16-h incubation at 30 °C, cells
were harvested (10 min at 4000×g). For cell lysis, the cells
were re-suspended in B-PER Bacterial Protein Extraction
Reagent (Thermo Scientific) supplemented with protease
inhibitor (cOmplete mini, EDTA-free, Roche), lysozyme
(Sigma Aldrich), and DNAse (Roche). After incubation
(1 h, RT) and centrifugation (10 min at 4000×g), the su-
pernatant (crude cell extract) was loaded to a column for
purification. The samples from the 50-ml cultivations were
loaded on to a HisTrap FF Crude 1-ml column (GE
Healthcare) equilibrated with 20 mM sodium phosphate,
0.5 M NaCl, 10 mM imidazole, pH 7.4. The column was
washed with the equilibration buffer, and bound protein
was eluted with a linear gradient from 10 to 500 mM im-
idazole. DERA containing fractions were pooled and the
buffer was changed to 50 mM Tris-HCl pH 7.5 by
EconoPac (BioRad) desalting columns. The protein purity
was verified with SDS-PAGE.
The Ec DERA mutants were purified from the small-scale
cultivations (3 ml and 10 ml) with 0.2-ml HisPur™ Ni-NTA
Spin Columns (Thermo Scientific) according to manufac-
turer’s instructions and the buffer was exchanged with PD-
10 (GEHealthcare) desalting columns. The protein concentra-
tions were determined bymeasuring the absorbance at 280 nm
and calculated using the theoretical epsilon based on the ami-
no acid sequence (monomer).
Cloning, protein expression and purification of
Klebsiella pneumoniae 1,3-propanediol
oxidoreductase (Kp PDOR)
Klebsiella pneumoniae 1,3-propanediol oxidoreductase (Kp
PDOR; UniProt Q59477) encoding gene dhaT with a N-
terminal 6× His-tag was codon optimised for E. coli and syn-
thesised by Integrated DNA Technologies and cloned into the
pBAT4 vector in a similar manner as described above for
DERA. For the codon-optimised nucleotide sequence, see
“GenBank accession numbers” section. Expression of Kp
PDOR was done in E. coli BL21(DE3) by cultivating the Kp
PDOR expression vector containing strain in 50-ml volume in
250-ml shake flasks in LB-medium (100 μg ampicillin/ml)
similarly as for DERA described above. Purification of Kp
PDOR was also done in the same way as for DERA. The
purified fractions of Kp PDOR were pooled and the buffer
was exchanged with EconoPac desalting columns to 50 mM
Tris-HCl pH 7.5, 2 mM DTT, 1 mM MnCl2.
Following DRP and DR cleavage reactions by DERA
enzymes
The cleavage of the natural DERA substrate, deoxyribose 5-
phosphate (DRP), was measured using 2-deoxyribose 5-phos-
phate sodium salt (Sigma-Aldrich) as a substrate in a coupled
enzyme system with triosephosphate isomerase (TPI) and glyc-
erol 3-phosphate dehydrogenase (GPD) from rabbit muscle
(Sigma-Aldrich) in ambient temperature. DERA activity on
DRP liberates glyceraldehyde-3-phosphate, which is reduced to
glycerol-3-phosphate by the supplementary enzymes TPI and
GDH. The latter reaction consumes NADH, which can be de-
tected by spectrophotometer. The reaction mixture contained
0.1μMpurified DERAwild-type or variant, 5 mMDRP, 3 units
of TPI, 2 units of GPD and 0.3 mMNADH in 50 mMTris-HCl,
pH 7.5, supplemented with 5 mM MgCl2. The reaction was
initiated by addition of DRP and followed by measuring the
decrease of absorbance at 340 nm using a Varioskan microtiter
plate reader (Thermo). DERA activity on non-phosphorylated
substrate 2-deoxy-D-ribose (DR, Sigma-Aldrich) was assayed
similarly in a coupled enzyme system with 4 units of alcohol
dehydrogenase (ADH) from Saccharomyces cerevisiae (Sigma-
Aldrich) using 50 mM DR and 2 μM purified DERA wild-type
enzyme or variant, and 0.3 mMNADH in 50 mM Tris-HCl, pH
7.5, supplemented with 5 mM MgCl2. Cleavage of DR by
DERA liberates acetaldehyde, which is converted to ethanol by
ADH in NADH consuming reaction.
Sequential aldol addition reaction of acetaldehyde by
DERA enzymes
The sequential aldol addition of acetaldehyde was monitored
by incubating 5 μM DERA with different amounts (10–50
Appl Microbiol Biotechnol
mM) of acetaldehyde in 50 mM Tris-HCl buffer pH 7.5 in
ambient temperature for 20 h. The reactions were stopped by
addition of acetonitrile (20 μl of reaction mixture + 80 μl of
acetonitrile), clarified by centrifugation and analysed with a
UPLC system (Waters) equipped with photodiode array de-
tector. An Acquity BEH Amide column (2.1 × 100 mm, 1.7
μm,Waters) was used in 40 °C with 0.6 ml/min flow rate. The
solvents used in the UPLC were eluent A: 50% acetonitrile/
50% H2O and 10 mM ammonium acetate pH 9 and eluent B:
95% acetonitrile/5% H2O and 10 mM ammonium acetate pH
9. The column was equilibrated with 99.9% B, and 5 μl of
sample was injected and eluted with program as follows: 0–
0.4 min isocratic 99.9% B, 0.4–0.5 min gradient to 60% B,
0.5–2.0 min gradient 30% B and 2–5 min isocratic 99.9% B.
The acetaldehyde concentration was followed by adsorption
at 285 nm, and the formation of the aldol addition product by
adsorption at 217 nm.
Aldol addition of formaldehyde and acetaldehyde by
DERA enzymes
The addition reaction of formaldehyde and acetaldehyde was
monitored by incubating 5 μM DERA with 2 mM formalde-
hyde and 2 mM acetaldehyde in 50 mM Tris-HCl buffer pH
7.5 in ambient temperature. The reaction was stopped by ad-
dition of 2,4,-dinitrophenylhydrazine (2,4-DNPH) and aceto-
nitrile, which also initiated the derivatisation reaction (Allen
1930). For derivatisation, typically 25 μl of the DERA reac-
tion mixture was transferred to an Eppendorf tube containing
70 μl of 2,4-DNPH mixture (5 μl of saturated 2,4-DNPH,
65 μl acetonitrile, and 30 mM phosphoric acid). The
derivatisation reaction was allowed to proceed at 22 °C for
1 h or overnight in + 4 °C. After derivatisation, the samples
were clarified by centrifugation and injected to an Acquity
BEH UPLC C18 column (2.1 mm × 50 mm, 1.7 μm,
Waters) equilibrated with 70% H2O, 30% acetonitrile and
eluted with isocratic elution with the equilibration buffer using
0.5 ml/min flow rate. The derivatised aldehydes were detected
by measuring the absorbance at 360 nm (Allen 1930).
Identification of the aldol addition product of
formaldehyde and acetaldehyde
Propanediol oxidoreductase is an NAD-dependent enzyme
that oxidises 1,3-propanediol (1,3-PD) to generate 3-
hydroxypropionaldehyde (3-HPA). Kp PDOR was incubated
with 30 mM 1,3-PD, 5 mMNAD, in 50 mM Tris-HCl buffer,
containing 2 mM DTT and 1 mM MnCl2, pH 7.5 in ambient
temperature. The aldehydes in the reaction were detected by
reversed-phase UPLC after derivatisation with 2,4-DNPH as
described above.
The mass of the product of DERA catalysed addition reac-
tion of 10mM formaldehyde and 10mMacetaldehyde after 2-
h incubation at 22 °C was analysed by LC-MS using a C18
column. After derivatisation with 2,4-DNPH, the reaction was
separated using 75:25 water plus 1% formic acid/acetonitrile.
Analysis of DERA catalysed aldol addition products by
NMR spectroscopy
NMR experiments were carried out at 22 °C in 50 mM Na-
phosphate buffer, pH 6.8, containing 10% of D2O (Aldrich).
Bruker Avance III NMR spectrometer equipped with a QCI
H-P/C/N-D cryoprobe was used. In 1D 1H experiments, the
water signal was suppressed by 4-s-long volume selective
presaturation (so-called NOESY presaturation) using
Bruker’s pulse program noesygppr1D. For 2D COSY,
TOCSY, HSQC and HMBC standard Bruker pulse programs
with water signal presaturation were used. In TOCSY, the
mixing time (DIPSI2) was 80 or 120 ms, and in HSQC, adi-
abatic inversion pulses were used and the 1H decoupling was
achieved by adiabatic CHIRP sequence. The long range
1H,13C coupling constant in HMBC was set to 8 Hz. The
chemical shifts were referenced to internal TSP (3-
propionic-2,2,3,3-d4 acid sodium salt, Aldrich). The spectra
were processed with Topspin 3.5, pl 7 software (Bruker).
Circular dichroism spectroscopy to determine the
thermostability
Temperature-induced unfolding of the purified DERA pro-
teins from different organisms was measured by circular di-
chroism (CD) spectroscopy. The purified DERAs were dilut-
ed in 10 mM Tris-HCl buffer, pH 7.5 to 3 μM concentration.
CD spectra were recorded from 240 to 190 nm using a 1 mm
cell and a bandwidth of 1 nm with Chirascan CD spectropho-
tometer (Applied Photophysics, UK) at 20 °C. The unfolding
curves were measured at 222 nm by gradually increasing the
sample temperature with a gradient of 2 °C/min until a tem-
perature of 90 °C was reached.
Development of machine learning (ML) models for
DERA mutant screening
A novel ML model was used to automatically predict sub-
strate specificities of DERA mutants based on Gaussian pro-
cesses, as summarised in Fig. 1. See the Supplementary ma-
terial Text S1 for a more detailed description of theMLmodel.
X-ray crystallography of Ec DERA variants
The three-dimensional structures for two Ec DERA variants
were determined by X-ray crystallography. The N21K mu-
tant, as a 1.2-mg/ml solution in 50 mM Tris-HCl buffer, pH
8.0, could be crystallised directly from the buffer. The
C47V/G204A/S239D mutant, as 1.3-mg/ml solution in
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50 mM sodium phosphate buffer, pH 7.5, precipitated imme-
diately in all conditions, and therefore, it was transferred to
50 mMTris-HCl, pH 8.0 buffer for crystallisation using a PD-
10 desalting column and concentrated to 3.2 mg/ml.
Concentration was done in a centrifuge using a Vivaspin 2
column with 10 kDa molecular weight cut-off.
Both protein samples were crystallised using hanging-drop
vapour diffusion. The N21K mutant was crystallised directly
from a crystallisation solution with 18–20% PEG4000, 0.2 M
magnesium formate and 0.1 M Tris-HCl pH 8.0. The
C47V/G204A/S239D mutant formed large, rugged needles
in 21% PEG3350, 0.2 M magnesium formate and 0.1 M
Bis-Tris, pH 6.5, which were crushed and used in streak
seeding, which produced good crystals in the same conditions
but 17–18% PEG3350. Prior to X-ray diffraction measure-
ments, crystals were soaked in solutions equivalent to their
respective crystallisation solutions plus 0.1 M ligand, D-2-
deoxyribose-5-phosphate (DRP), for 2 days.
Crystals were measured at European synchrotrons. They
were mounted in nylon loops in cryoprotectant solutions
equivalent to their respective crystallisation solutions but with
40% PEG, stored in liquid nitrogen and sent to the synchro-
trons for remote measurement. Crystals of the N21K mutant
were measured on the ID30A-1 beamline at the European
Synchrotron Radiation Facility (ESRF), and crystals of the
C47V/G204A/S239D mutant were measured on the I24
beamline at Diamond Light Source (DLS). Autoprocessed
MTZ files generated by EDNA_proc and xia2-3dii programs
were selected for structure determination for crystals mea-
sured at ESRF and DLS, respectively.
In addition, a large crystal of the N21K mutant was
measured using the home X-ray diffractometer: Nonius
FR591 rotating anode X-ray source by Bruker, mar345dtb
goniometer system and mar345 image plate detector by
X-ray Research (marXperts). The crystal was transferred
to a cryoprotectant solution with 40% PEG4000, 0.2 M
magnesium formate and 0.1 M Tris-HCl, pH 8.0 and
placed into the sample holder in a nylon loop, where it
was cooled down to constant 100 K in cold nitrogen
stream. The detector was set to the minimum allowed
distance of 150 mm, equivalent to 1.86 Å resolution limit.
A data set was collected, and the crystal diffracted beyond
Fig. 1 Illustration on the machine learning (ML) framework used in this
work. The DERAprotein structure is encoded as a contact map (a), which
is combined with multiple node and edge substitution matrices to
compute a graph kernel (b). We performed multiple kernel learning
(MKL) (c) to find an optimised kernel to be used in Gaussian process
predictive model (d). The kernel matrix measures variant similarities
informative for substrate specificity. The substrate specificity predictive
model is trained using experimental data
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the resolution limit. Images were processed with XDS
program package (Version November 1, 2016).
All structure determination calculations were done with
PHENIX software suite (Moriarty et al. 2009; Chen et al.
2010; Adams et al. 2010). Phasing was done using
phenix.phaser (McCoy et al. 2007) molecular replace-
ment, and previously published wild-type DERA structure
(PDB entry 1KTN, no article published) was used as ini-
tial model. Mutations were done manually in Coot
(Emsley et al. 2010) after molecular replacement.
Structures were then refined using phenix.refine
(Afonine et al. 2012). Water molecules were first added
using the “Update waters” option and later checked and
corrected manually. Appropriate ligands were placed in
the active sites, and the aldehydes bound as Schiff base
were connected to the amino group of the catalytic lysine
with appropriate geometry restraints. Presence of partial
DRP in the N21K mutant structures was further confirmed
by calculating Polder maps (Liebschner et al. 2017). For
the final refinement rounds, weight optimisation options
were enabled.
GenBank accession numbers
The nucleotide sequences of codon-optimised DERA and
PDOR-coding genes used in this study can be found in
the GenBank with the following accession numbers:
MT702750 for DERA-coding gene from E. coli ,
MT702753 for DERA-coding gene from Geobacillus,
MT702754 for DERA-coding gene from Thermus
thermophilus, MT702748 for DERA-coding gene from
Coccidioides immitis, MT702749 for DERA-coding gene
from Lactobacillus brevis, MT702752 for DERA-coding
gene from Talaromyces islandicus, MT702751 for
DERA-coding gene from Aspergi l lus niger and
MT682136 for Klebsiella pneumoniae dhaT gene.
Results
Selecting the most suitable DERA enzyme for the
protein engineering work
Several known DERA enzymes of bacterial and fungal origin
were initially considered as a target enzyme for the protein
engineering work. For the proper comparison, we decided to
express in E. coli the DERA aldolases from E. coli,
Geobacillus sp., Thermus thermophilus, Lactobacillus brevis,
Coccidioides immitis, Aspergillus niger and Talaromyces
islandicus. The characterisation data of the purified enzymes
is shown in Table 1. All seven DERAs were shown to be
promiscuous, accepting both the natural substrate DRP and
the non-phosphorylated version, DR. Moreover, acetaldehyde
was also shown to be an acceptor substrate for all the
characterised DERAs (as measured in the addition reaction).
As high expression level and good thermostability were also
considered to be relevant properties, E. coli (Ec) DERA was
chosen as the target for our mutagenesis work.
Setting up the analytics for the DERA-catalysed
reactions
The activity measurements for DERA wild-type and mutants in
the cleavage direction, e.g. cleavage of the natural substrate DRP
and the non-phosphorylated substrate DR,were carried out based
on the methodology described in the literature. These methods
are applicable also with crude cell extracts (data not shown), but
we decided to purify the enzymes to be able to accurately com-
pare the specific activities of the different DERA variants (in-
cluding different DERAs and Ec DERA mutants).
The assay for acetaldehyde addition activity was set up for
LC using an amide column in alkaline conditions. It was no-
ticed that during the course of the DERA reaction, a product
peak appeared (Fig. S1), which could be detected by absorption
Table 1 Characterisation of seven purified DERA enzymes, expressed in E. coli and purified with a His-tag
Microbial source
of the DERA enzyme
Yield of purified protein
from 50-ml cultivation
Relative activity
on 5 mM DRPa
Relative activity
on 50 mM DRa
Relative activity
on 30 mM acetaldehydea
Tm (°C)
b
E. coli 12 mg 1 1 1 65 ± 1
Aspergillus niger 2.1 mg 0.3 1.0 0.4 48 ± 1
Talaromyces islandicus 2.5 mg 0.3 0.6 0.9 47 ± 1
Geobacillus sp. 3.8 mg 0.4 1.4 1.4 75 ± 1
Thermus thermophilus ~ 1 mg 0.1 0.7 0.7 ≥ 90
Coccidioides immitis 1.4 mg 0.3 0.8 1.1 39 ± 1
Lactobacillus brevis 1.7 mg 0.6 0.3 1.2 38 ± 1
DRP deoxyribose-5-phosphate, DR deoxyribose
a Activities are presented relative to E. coli DERA activities
b Thermostability (Tm) of the purified protein was determined with CD spectroscopy
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at 217 nm. Themain product of DERA activity on acetaldehyde
has been shown to be an aldol addition product of three acetal-
dehyde molecules in a sequential reaction, where DERA first
adds two acetaldehydes to form an C4 aldehyde (3-
hydroxybutanal), which is then once more coupled with acet-
aldehyde into a C6 product, 2,4,6-trideoxyhexose. This product
cyclises spontaneously to a hemiacetal and is thus removed
from the reaction (Gijsen and Wong 1994). The C6 product
formation from the DERA-catalysed reactions could not be
quantified in the LC assay due to the fact that 2,4,6-
trideoxyhexose is not commercially available as a standard.
However, the identification of the formed cyclic
trideoxyhexose product was verified by NMR. In the NMR
experiments, several products from the enzymatic reaction were
observed. After identifying the different spin systems from
TOCSY spectra, their structures were determined by standard
2D NMRmethods and the chemical shifts were compared with
those published in Dick et al. (2016). The main products were
the first aldol addition product 3-hydroxybutanal (17%) and the
second aldol addition product that has undergone a spontaneous
cyclisation to two anomers of pyranose rings (73% and 10%).
In addition, a very small amount of crotonaldehyde was detect-
ed, a condensation product from two acetaldehyde molecules,
that has been reported to be a side-reaction product of DERA
(Dick et al. 2016).
Acetaldehyde addition reaction was carried out using acetal-
dehyde as a sole substrate, i.e. acetaldehyde acts both as acceptor
and donor substrate. In the literature, very high acetaldehyde
concentrations (e.g. 300–500mM) are often used to demonstrate
the synthesis of 2,4,6-trideoxyhexose with DERA. However,
high acetaldehyde concentrations have also been shown to inhibit
the DERA activity (Jennewein et al. 2006; Dick et al. 2016;
Bramski et al. 2017). The conditions for the enzymatic acetalde-
hyde addition reaction were thus chosen so that roughly saturat-
ing substrate concentration of 30 mM was used. The acetalde-
hyde standards were reproducible in our LC method; however,
the acetaldehyde concentrations in the presence of DERA, mea-
sured before or after incubation, were noisier. This was assumed
to be because of covalent binding of the acetaldehyde to the
enzyme protein (Dick et al. 2016).
In order to analyse DERA-catalysed addition reaction of
acetaldehyde with another aldehyde, activity assay based on
derivatisation of the aldehydes with 2,4-DNPH in acidic con-
ditions, followed by a reversed-phase LC separation with UV
detection, was set up. This method allowed detection of the
aldehyde substrates as well as formed aldol addition products
present in the DERA reactions.
About the DERA protein engineering approaches in
this work
Engineering of the substrate specificity is often attempted
through rational mutagenesis, targeted near the active site or
the substrate binding area. Even though the 3D structure of Ec
DERA is available in high resolution and also in complex with
the natural substrate DRP (Heine et al. 2001), it was challeng-
ing to rationally design mutations towards improved activity
on small non-phosphorylated aldehydes. On the other hand,
directed evolution including randommutagenesis to the whole
gene, or even random mutagenesis to a targeted area, puts a
stress on screening of the activities in high throughputmanner.
In the present study, we used targeted mutagenesis during the
1st round to create single amino acid mutants of Ec DERA.
The most beneficial mutants were then combined based on
activity data to create double and triple mutants.
Furthermore, saturation mutagenesis at certain amino acid
spots was also carried out. Finally, during the 3rd round, dou-
ble or triple point mutants were created using machine learn-
ing algorithm predictions, explained in more details in
Supplementary section and below. Altogether, roughly 150
Ec DERA mutants were characterised during the course of
the work.
Site-directed mutagenesis to make single amino acid
mutations to Ec DERA (1st round)
Altogether, 69 single Ec DERA mutants, targeting 24 amino
acid positions, were created with site-directed mutagenesis,
expressed in E. coli as His-tagged proteins, and purified with
Ni-NTA spin columns. The amino acid positions to be
mutagenised were chosen mainly by examining the high-
resolution crystal structure in complex with the native Ec
DERA substrate, DRP (Heine et al. 2001; PDB id. 1JCL). In
addition, sequence alignments of DERAs from different ori-
gins were utilised to find conserved amino acids and possible
targets for consensus mutations. Moreover, the online tool
HotSpot-Wizard (Bendl et al. 2016) and literature were
utilised when selecting the residues to be mutated. Most of
the mutations were targeted in close vicinity (maximum 4 Å
distance) of the active site and the substrate binding pocket
(Fig. 2). The activities of the purified Ec DERA variants were
measured with three different substrates: DRP and DR for the
cleavage reaction and acetaldehyde for the aldol addition re-
action. Altogether, 30 variants having single-point mutations
had clearly reduced specific activity (20% or less) towards the
natural substrate DRP as compared with the wild-type enzyme
(Figs. 3 and 4 and S2). Of these 30 Ec DERA variants, five
showed additionally improved activity on acetaldehyde aldol
addition, i.e. the Ec DERA mutants G204A, S239E, L17G,
G171A and G171S (Fig. S2).
Ec DERA variants containing two or three amino acid
mutations (2nd round)
Altogether, 62 double or triple Ec DERA mutants were
created by (a) manually combining the most interesting
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single mutations and (b) by using saturation mutagenesis
on selected spots, as described in more details under
Materials and methods section. In the manual combina-
tion, one of the selection criteria used was to pick muta-
tions that affected the acetaldehyde addition activity. The
Ec DERA variants included 34 double or triple mutants,
which were combined from the single mutants based on
the activity data. In addition, 28 double mutants were
created using saturation mutagenesis on amino acids
C47, I166 and S238. In each case, these mutants were
made on top of the Ec DERA variant N21K. The rational
in picking the spots for the saturation mutagenesis was
that these three amino acid positions C47, I166 and
S238 were found to affect favourably to the acetaldehyde
addition reaction (Fig. 3). Moreover, C47 has been previ-
ously shown to be a target for inactivation by aldehydes
(Dick et al. 2016) and based on the Ec DERA wild-type
complex structure. In addition, S238 is hydrogen bonded
to the phosphate group of the natural substrate DRP.
Overall, several interesting variants having low activity
on both DRP and DR substrates and improved acetalde-
hyde addition activity were discovered among all the
screened double and triple Ec DERA variants in the 2nd
mutagenesis round, e.g. N21K/C47V, N21K/C47L,
N21K /C47F , N21K /C47S , a nd N21K /S238G .
Additionally, the Ec DERA variants S239/V206I/L17H,
S239/V206I/I166M, and S239D/V206I showed reduced
activity on DRP and improved acetaldehyde addition ac-
tivity (Figs. 4 and S3). It should be also noted that in most
cases, no additivity effect of point mutations in terms of
activity data could be detected.
Ec DERA variants created using machine learning (3rd
round)
A novel machine learning (ML) model to automatically pre-
dict substrate specificities of DERA mutants based on
Gaussian processes was developed. Our goals were to train
the specificity prediction functions from specificity observa-
tions and use these subsequently for screening new potential
Ec DERA variants. See the Supplementary material Text S1
for a technical description of the development and training of
the ML model.
A machine learning model was trained using the data from
the available EcDERAmutants, consisting of (i) the 69 single
point mutants and (ii) the 62 double or triple point mutants, in
total 131 mutants. Each mutant had measured data on DRP,
DR and acetaldehyde specificity. The ML model was trained
to predict all three substrate specificities. In Fig. S4, the
trained combinations of substitution models are shown. The
DRP model ended up using six different substitution models
whereas the DR model used five, with amino acid interaction
features having most predictive information. The acetalde-
hyde model only used four substitution models with contact
energy and packing features having highest weights.
The predicted and measured activity data of the Ec DERA
mutants are shown in Fig. S5. The ML model achieved cross-
validation test correlation on the first two rounds of 0.57 for
DRP, 0.81 for DR and 0.54 for acetaldehyde, respectively.
The 131 data points were sufficient for the ML model to
explain the substrate specificity of each of them.
After this, we screened in silico all possible Ec DERA
variants with 1–3 amino acid mutations using the ML model,
Fig. 2 The 3D structure of covalent complex of E. coliDERA with DRP
(PDB id. 1JCL Heine et al. 2001). Mechanistically relevant water mole-
cule is shown as light-blue sphere. Residues N21, C47, I166, G171,
G204, S238 and S239, which had the most beneficial effects, mutated
in the study are shown in orange. The Schiff-base forming lysine (K167)
is shown in green
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Fig. 3 Heatmap displaying the 2-
deoxyribose 5-phosphate (DRP)
and 2-deoxyribose (DR) cleaving
activities and acetaldehyde addi-
tion activities of all Ec DERA
single point relative to the wild-
type enzyme (wt)
Appl Microbiol Biotechnol
in total 48,000 new variants. These were sorted based on the
predicted acetaldehyde specificity, subtracted with DRP spec-
ificity to find the most probable candidates with high acetal-
dehyde but low DRP specificity. From the top 50 best esti-
mated variants, 18 mutants were manually chosen for in vitro
mutagenesis experiments.
The results of these 18 Ec DERA variants (containing two
or three point mutations) showed that all except three had
improved activity on acetaldehyde addition, and five of the
variants had more than two-fold improved acetaldehyde addi-
tion activity (Figs. 4 and 6). In addition, for all 18 Ec DERA
mutants, the DR and DRP activity was almost completely
abolished (Figs. 4 and 6). The Fig. S6 shows the correlations
of the 18 final variants, which indicate a 0.99 correlation for
DRP and DR due to their successful specificity removal and a
0.96 correlation between estimated and measured acetalde-
hyde specificity.We note that one should not directly compare
these correlations to the cross-validation correlations due to
active selection procedure of the 3rd round variant.
Crystal structure analysis
The crystal structures of two variants of Ec DERA were de-
termined, in order to elucidate mutation-induced changes in
the 3D protein structure. The crystal structure of Ec DERA
N21K variant, which had lowered specific activity on DRP,
and wild-type like activity on DR and acetaldehyde, was de-
termined with and without the ligand, D-2-deoxyribose-5-
phosphate (DRP). In addition, the crystal structure of one of
the best Ec DERA variants, C47V/G204A/S239D, having
improved activity towards acetaldehyde and basically no ac-
tivity on DRP or DR, derived from the 3rd mutagenesis
around, was determined from the crystal soaked with DRP.
Diffraction resolutions for all three structures were high (1.5 to
1.9 Å) and the crystallographic R-factors were very low
(Table S2), indicative of high quality 3D structures in each
case. The determined three 3D structures were superimposed
with the crystal structures of the Ec DERA wild-type without
(pdb code 1p1x, 1.0 Å resolution) and with a ligand complex
(1-hydroxy-pentane-3,4-diol-5-phosphate)(1jcl, 1.1 Å resolu-
tion), to analyze mutant-induced changes in the 3D structures.
The complex structure of EcDERAN21Kmutant revealed
binding of the reaction product from DRP cleavage, i.e.
glyceraldehyde-3-phosphate (C3P), to the acceptor site in
one of the two protein molecules in the asymmetric unit
(Fig. 5a). A similar conformational change in the loop around
residue S238 in both the Ec DERA N21K mutant and wild-
type structures can be seen upon glyceraldehyde-3-phosphate
binding, when uncomplexed and complexed crystal structures
are compared. In addition, in both N21K crystal structures,
Fig. 4 Summary of the substrate specificities of Ec DERA variants on
deoxyribose-5-phosphate (DRP), deoxyribose (DR) and acetaldehyde
(rows) over three mutagenesis rounds (columns), demonstrating that the
ML-optimised mutants have abolished activities on DRP and DR, and
increased acetaldehyde specificity. The white circles indicate specificities
of individual DERA variants, and the shaded violin plots indicate
smoothed vertical histograms (i.e. overall number as percentages from
the total number of mutants)
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there are slight (about 0.2 to 0.4 Å) movements in the posi-
tions of altogether three active site loops containing residues
G171, G204 and L20, respectively, when compared with the
wild-type DERA crystal structure. The N21K mutation is lo-
cated in the third loop. These small movements slightly nar-
row the access to the active site of the N21K variant and may
thus contribute to the decreased activity against DRP in many
of the N21K containing double mutants tested in this work.
The structure of Ec DERA C47V/G204A/S239D variant
was determined from crystals after soaking with DRP. The
crystal structure showed a presence of a very small covalent
adduct to the catalytic amino acid K167 in both molecules in
the asymmetric unit. The electron density map showed elon-
gated electron density corresponding to approximately two
carbon atoms. In the refinement, it was modelled as an imine
group representing a reaction intermediate. No binding of
DRP or glyceraldehyde-3-phosphate could be detected. This
could imply that binding of the DRP is clearly diminished in
the C47V/G204A/S239D variant (Fig. 5b). The conforma-
tional differences in this variant as compared with the Ec
DERA wild-type structure are clearly detectable. The confor-
mation of the loop containingmutation G204A has pushed the
position of its Cα atom by 1.0 Å towards active site, thus
narrowing it. In addition, there are clear changes in the loop
structure containing the S239D mutation. Because the resi-
dues of this loop participate in phosphate binding (of
glyceraldehyde-3-phosphate acceptor), the S239D mutation
would probably decrease binding of DRP both by introducing
a negatively charged amino acid residue (phosphate being also
negatively charged) and by narrowing the active site entrance.
On the other hand, the C47Vmutation, located relatively close
to the catalytic K167 residue (about 5 Å), has caused only
minimal alteration in the position of this amino acid residue,
as it is located in the middle of β-strand.
Further substrate promiscuity testing of Ec DERA
variants
The goal of the protein engineering work was to improve the
substrate specificity towards smaller, non-phosphorylated al-
dehydes over glyceraldehyde-3-phosphate. Acetaldehyde is a
two-carbon aldehyde, and the only shorter aldehyde is form-
aldehyde, which is the simplest existing aldehyde.We decided
to test also formaldehyde as acceptor in the DERA reaction
catalysed by Ec DERA variants. The reference test with the
wild-type Ec DERA enzyme indicated that this was already
able to add formaldehyde to the acetaldehyde donor. The ver-
ification of the aldehyde addition reaction was carried out
using the reversed-phase chromatography after derivatisation
with 2,4-DNPH. Here, the product by EcDERA catalysis was
found to elute with an identical retention time to the product of
Kp PDOR catalysed oxidation of 1,3-propanediol (Fig. S7),
which is known to be 3-hydroxypropionaldehyde (3-HPA)
(Johnson and Lin 1987). Furthermore, the mass m/z
255.0729, which is identical to 2,4-DNPH derivatised 3-
HPA, was detected in the reaction, also suggesting 3-HPA to
be formed byEcDERA from formaldehyde and acetaldehyde.
Moreover, the DERA products of formaldehyde with acetal-
dehyde were identified as 3-hydroxypropionaldehyde (30%)
and the corresponding hydrate (70%) by 1D and 2D NMR
experiments. The 1H NMR spectrum of the products and the
product structures are shown in Fig. S8. Interestingly, the
DERA addition reaction products of acetaldehyde with itself
were not observed here at all.
After this, altogether, 140 Ec DERA variants were assayed
for addition activity on formaldehyde and acetaldehyde. Of
these, six Ec DERA variants were found to have improved
activity as compared with the wild-type enzyme (Fig. S9).
Two of the mutants had single mutations, two were double
Fig. 5 The superimposition of the crystal structures of the Ec DERA
wild-type and two variants around the active site as stick models. Ec
DERA wild-type structures as uncomplexed and complexed form are
shown in grey. The covalently bound 1-hydroxy-pentane-3,4-diol-5-
phosphate is in purple. a The superimposition with the uncomplexed
and complexed form of Ec DERA N21K variant. Variant structures in
uncomplexed and complexed forms are shown in green and bound ligand,
glyceraldehyde-3-phosphate, in purple. b The superimposition with the
uncomplexed form of Ec DERA C47V/G204A/S239D variant. The var-
iant structure is shown in green and the mutated residues are in cyan.
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and two triple mutants. The relatively small number of Ec
DERA variants with higher activity on formaldehyde addition
to acetaldehyde as compared with the wild-type enzyme was
not surprising, as both the screening and the machine learning
prediction algorithmwere set up tomaximise the acetaldehyde
addition reaction.
Discussion
Deoxyribose-5-phosphate aldolases (DERAs) are acetalde-
hyde-dependent, Class I aldolases catalysing in nature a re-
versible aldol reaction between an acetaldehyde donor (C2
compound) and glyceraldehyde-3-phosphate acceptor (C3
compound, C3P) to generate deoxyribose-5-phosphate, DRP
(C5 compound). The interesting feature is the substrate pro-
miscuity as DERA enzymes have been shown to accept a wide
range of aldehydes as acceptor molecules, thus offering a bio-
catalytic alternative for a (stereo)selective synthesis of C–C
bonds. Substrate specificity on the donor substrate side is
stricter but recent biodiversity screen has revealed that some
DERAs also display nucleophile substrate promiscuity
(Hernández et al. 2018; Chambre et al. 2019). Furthermore,
DERA enzymes can carry out a tandem reaction with acetal-
dehyde as a sole substrate, leading to formation of a C6 prod-
uct, 2,4,6-trideoxyhexose, which cyclises spontaneously and
is removed from the reaction. DERA enzymes have been
utilised in large-scale synthesis of pharmaceutical intermedi-
ates, i.e. statin precursors and pyranoid building blocks, as
well as preparation of different types of deoxysugars, deoxy-
ketoses and deoxy-sialic acid (Haridas et al. 2018). Despite of
being promising enzymes for application purposes, there are
still some challenges related to their usage. In particular, en-
zyme inactivation under synthesis conditions represents a ma-
jor obstacles (Jennewein et al. 2006; Dick et al. 2016; Bramski
et al. 2017), and thus, variants having improved substrate
binding towards non-natural substrates and/or resistance to-
wards high aldehyde concentrations are desired.
The 3D structures of several DERA enzymes have been
solved, and there are also a few complex structures available.
These have revealed that despite of relatively low sequence
identity, all DERA enzymes have the ubiquitous TIM (α/β)8-
barrel fold where the catalytic amino acids as well as other
amino acid residues around the active site seem to be relative-
ly well conserved (Heine et al. 2001; Haridas et al. 2018). The
DERA reaction proceeds via Schiff base formation between
an active site lysine residue (K167 in EcDERA) and the donor
acetaldehyde substrate. The active site of DERA is located in a
deep binding cleft, where the donor acetaldehyde binds to the
bottom of the cleft and the acceptor glyceraldehyde-3-
phosphate to the upper part, near the cleft entrance. Binding
of the substrates to the active site cleft is mediated through
hydrogen bonds, either directly or through water molecules.
Concerning the acceptor site, the hydrogen bonds are particu-
larly directed to the phosphate group of the native substrate
(glyceraldehyde-3-phosphate) (Heine et al. 2001; Heine et al.
2004). Based on the published Ec DERA complex structures,
residues specific for phosphate-binding are the backbone am-
ide groups of S238 and G205 and via a water molecule the
residues G204, V206, S239 and G171. Residue K172 pro-
vides both a counter-charge and forms a hydrogen bond (via
a water molecule) with the phosphate group (Heine et al.
2001).
In this work, we wanted to study the substrate specificity of
DERA with various protein engineering approaches, includ-
ing also machine learning methods. We set as our goal to
improve the overall performance of DERA on utilising non-
phosphorylated short aldehydes (C3 and C2). Initially, we
characterised seven different purified DERA wild-type en-
zymes of bacterial and fungal origin and found that several
of them were promiscuous and could also accept non-
phosphorylated aldehydes as the acceptor substrate
(Table 1). E. coli (Ec) DERA was chosen for the protein en-
gineering work as it showed relatively good promiscuous ac-
tivity towards the desired reactions and had high expression
level and good thermostability (Table 1). Additionally, high-
resolution complex structures ofEcDERA exist both with and
without bound substrate (Heine et al. 2001; Heine et al. 2004),
and some mutagenesis studies to change its substrate prefer-
ence have also been carried out, thus providing a good starting
point for semi-rational mutagenesis approaches.
DERA mutagenesis to alter the substrate specificity was
targeted to the active site of the enzyme (Fig. 2). Initially,
Web server HotSpot-Wizard, 3D structures of Ec DERA
(Heine et al. 2001; PDB id. 1JCL) and literature were utilised
when selecting the amino acid residues to be mutated. First
mutagenesis round DERA variants were made as single amino
acid mutants, and in the 2nd mutagenesis round, beneficial
mutations were combined. Furthermore, saturation mutagen-
esis at certain amino acid spots was also carried out. The 3rd
round of mutagenesis was carried out using machine learning
(ML)-guided approach. The specific activities of the purified
EcDERA variants were measured initially with three different
substrates: (1) DRP (cleavage reaction), (2) DR (cleavage re-
action), (3) acetaldehyde (aldol addition reaction using acetal-
dehyde both as the donor and acceptor substrate). Altogether,
roughly 150 purified Ec DERA mutants, having one to three
point mutations, were characterised during the work. Several
of the Ec DERA variants showed clear change in their sub-
strate spectra (Figs. 3, 4, 6 and S4–S5). The most promising
variants had substantially reduced, or completely abolished
activity particularly towards the natural substrate (DRP),
while showing activity on acetaldehyde addition reaction.
Interestingly, we also discovered that most of the tested
DERA wild-type enzymes could also accept, besides alde-
hyde, formaldehyde (C1 aldehyde) as the acceptor molecule.
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This prompted us to test the Ec DERA variants on formalde-
hyde (C1) utilisation (i.e. aldol addition reaction between ac-
etaldehyde and formaldehyde). The results demonstrated that
some of the mutants had also altered preference towards form-
aldehyde (C1 aldehyde), the following six variants being the
most potent: L17H, N21D, G171T, N21R/R207E, V206I/
S239R, N21R/D206I/S239R and E67D/N206I/S239R (Fig.
S9). Interestingly, the acetaldehyde and formaldehyde activi-
ties did not always correlate, and none of the 3rd round vari-
ants (from the ML-guided mutagenesis) that had clear prefer-
ence for acetaldehyde did not perform particularly well when
formaldehyde was offered as an acceptor aldehyde. On the
other hand, as discussed more thoroughly below, this also
demonstrates the power of the ML-guided mutagenesis com-
bined with screening.
During the work, a sample-efficient machine learning
method for designing the optimal mutation strategy for protein
engineering was developed. The proposed Gaussian process
model is a principled statistical model that excels in moderate
to low data settings. The model learns the posterior distribu-
tion of specificity functions from observations, while simulta-
neously performing feature learning for added interpretability
of substitution model choices. The Gaussian process model
excelled at interpolation and moderate extrapolation of the
DERA structure. The results from the 3rd round of Ec
DERAmutagenesis guided with machine learning (ML) algo-
rithm aiming at high activity on acetaldehyde addition reac-
tion, and low activity on DRP and DR substrates is shown in
Fig. 6. As can be seen, all 18 variants tested had basically
abol ished act ivi ty towards the nat ive DRP (i .e .
glyceraldehyde-3P acceptor) as well as towards the non-
phosphorylated DR substrate (i.e. toward glyceraldehyde ac-
ceptor). Moreover, 15 out of 18 variants tested had increased
target specificity towards the C2 acceptor aldehyde. Thus, our
ML model was able to successfully extrapolate from the
characterisation data novel mutant combinations with desired
specificity. The usage of the ML model enhanced the muta-
genesis work by a dramatic improvement over the convention-
al mutant selection procedures and these type of methods are
clearly useful to speed up the protein engineering work.
The five best Ec DERA variants having clearly improved
substrate specificity towards acetaldehyde (Fig. 6) were (1)
C47V/G204A/S239D, (2) N21S/C47E/G204A, (3)
C47V/G204A/S239E, (4) C47V/G204A and (5)
N21K/C47V/G204A. By examining all our mutant data, we
conclude that mutations to the amino acid residues N21, C47,
I166, G171, G204, S238 and S239 seemed to have the most
beneficial effects on changing the substrate specificity (Figs.
3, 6, S2-S3). Most of these residues (i.e. G171, G204, S238
and S239, N21) are according to the structural data (by others
and us, see also below) involved in binding the phosphate
group of the glyceraldehyde-3-phosphate acceptor substrate.
Residue I166 is located more distant to the active site, in the
loop underlying the active site lysine residue K167. The rea-
son for I166 mutations affecting to the substrate specificity is
not clear; however, others have also noted that mutations to
this spot affect the substrate binding (Jennewein et al. 2006).
Furthermore, the conserved residue C47, which is located at
the bottom of the active site cleft, seems to be able to form in
some circumstances covalent adducts with aldehydes leading
to enzyme inactivation (Dick et al. 2016; Bramski et al. 2017).
All our best five mutants on acetaldehyde addition reaction
contained a mutation C47V and it is plausible that this muta-
tion promoted the enzymatic reaction by relieving the alde-
hyde inhibition. Interestingly also, the DERA from the hyper-
thermophile Archaea Aeropyrum pernix has naturally a Valine
residue at this position (C47 in Ec DERA) (Sakuraba et al.
2003).
In order to further rationalise our protein engineering re-
sults, we determined the crystal structures of the two Ec
Fig. 6 The characterisation data
of the 18 Ec DERA variants
containing two or threemutations,
created by optimisation with
machine learning algorithm.
Cleaving activities on 2-
deoxyribose 5-phosphate (DRP)
and 2-deoxyribose (DR) and on
acetaldehyde addition activity are
shown as relative activities
compared with the wild-type Ec
DERA (WT)
Appl Microbiol Biotechnol
DERA variants C47V/G204A/S239D and N21K as ligand
complexes and compared these to the solved Ec DERA
wild-type structures, as explained in more details under
Results section (Fig. 5 and Table S2). We conclude that when
aiming for improved binding of small non-phosphorylated
aldehydes, mutations that narrow the substrate binding cleft
near the entrance and/or affect to the binding of the substrate,
in particular the phosphate group seem to be important.
However, as evident from our variant data, purely rational
design of the mutants remains challenging, and the substrate
specificity improvement clearly benefited from saturation mu-
tagenesis combined with ML-guided mutagenesis ap-
proaches. Overall, we could demonstrate that the synthetic
utility of DERA enzyme may be substantially increased using
protein engineering approaches.
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